
The present study was designed to address the question of the early identification of patients at risk of developing zzso zzso delayed zzso This study included zzso clinical, biological and pharmacological data and was conducted on 110 consecutive patients treated by zzso zzso A previously validated zzso zzso zzso evaluation was performed in all zzso A total of 110 cycles was zzso Delayed vomiting zzso occurring between day 3 and day 7 following zzso zzso was observed in zzso of zzso Among the tested zzso the occurrence of delayed zzso was significantly related to elevated zzso zzso platinum concentration zzso 16 h after the end of zzso zzso and to low plasma zzso concentration zzso 48 h before zzso zzso zzso for delayed zzso were established for zzso platinum and zzso at 60 zzso and 58 zzso zzso In the zzso of patients with zzso determination, this later zzso was the only significant predictor of delayed zzso zzso cycle number, primary cancer location and age were not associated with the risk of developing delayed zzso The ability to select patients at risk of delayed vomiting may offer a practical means of targeting administration of specific zzso 

